Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy

Name: Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy
License: Public Domain

Sheba Medical Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic or locally advanced nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 451468
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.